rassf3 antikoerper, MGC80235 antikoerper, rapl antikoerper, maxp1 antikoerper, nore1 antikoerper, MGC69348 antikoerper, RASSF5 antikoerper, AW212023 antikoerper, AW322379 antikoerper, Ras association (RalGDS/AF-6) domain family member 3 S homeolog antikoerper, Ras association (RalGDS/AF-6) domain family member 3 antikoerper, Ras association domain family member 3 antikoerper, rassf3.S antikoerper, rassf3 antikoerper, RASSF3 antikoerper, Rassf3 antikoerper
Hintergrund
The RAS oncogene (MIM 190020) is mutated in nearly one-third of all human cancers. Members of the RAS superfamily are plasma membrane GTP-binding proteins that modulate intracellular signal transduction pathways. A subfamily of RAS effectors, including RASSF3, share a RAS association (RA) domain.